drugset / Trial / NCT00070161
Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor
Phase 2
Completed
68 enrolled
Wake Forest University Health Sciences
National Cancer Institute (NCI) · collab
RandomizedSingle-groupDouble-blindSupportive care
Summary
RATIONALE: Donepezil and EGb761 may be effective in improving neurocognitive function (such as thinking, attention, concentration, and memory) and may improve quality of life in patients who have undergone radiation therapy to the brain. PURPOSE: This phase II trial is studying how well donepezil or EGb761 works in improving neurocognitive function in patients who have undergone radiation therapy for primary brain tumor or brain metastases.
Timeline
- Start
- 2001-07-01
- Primary completion
- 2005-05-01
- Completion
- 2012-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donepezil | Small molecule | 10 mg | Oral |